7. Image fusion for diagnostic and therapeutic use: Used to diagnose medical problems, both anatomic and physiologic in nature, as well as to assist minimally invasive procedures - such as stent placement or tumor ablation.
6. Live attenuated influenza vaccine for children as young as six months: Nasal drops containing live attenuated flu can be used as a vaccine in lieu of needles, and provide effective protection from influenza for this high-risk population.
5. New oral anticoagulant drugs for treating and prevent thrombosis: Newer anticoagulant treatments, which include low molecular weight heparins, are being introduced with the goal of curbing complications such as bleeding and thrombosis.
4. Convergence of advances in genome scanning and informatics to support clinical applications: Genetic testing that can be used to develop personalized risk assessments and disease management plans for variety of genetically caused diseases.
3. RNA-based therapeutics: This particular innovation uses RNA antisense technology to treat patients who are unable to reach their targeted cholesterol levels with statins alone or who are statin intolerant. The therapy is intended to reduce the production of ApoB-100, a protein that carries certain forms of cholesterol and triglycerides in the bloodstream.
2. Percutaneous aortic heart valves: For high risk patients, a technique has been developed which involves inserting a new balloon expandable wire mesh valve with internal valve leaflets. The valve is inserted through a groin or small chest wall incision and then fed up through a catheter into position with X-ray screening and the balloon inflated to secure the new valve.'/>"/>
|SOURCE Cleveland Clinic|
Copyright©2007 PR Newswire.
All rights reserved